PepTcell
CompanyUnited KingdomFounded 2003
PepTcell develops one asset, in phase 3 (FLU-v in influenza). Mostly vaccine acting on inflammation; based in the United Kingdom, founded in 2003.
- 1
- Asset
- Furthest stage
- Phase 3
- 2
- Trials
- 0
- Signals
Pipeline
1Inactivated influenza virus vaccine inducing protective antibody responses
Phase 3, Vaccine, Inflammation, influenza, influenza immunization
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms2
- Trials2
- Similar companies6